Paul Aliu

Paul is the Head of Medical Excellence, Operations and Governance at Novartis, with responsibility for defining and governing enterprise-wide medical standards and policies, ensuring timely clinical trial disclosure and transparency; and the oversight, standards, training, systems and operations for compassionate use/expanded access, scientific grants, peri- and post-registration medical programs (e.g. Investigator initiated trials, research collaborations, non-interventional studies, registries, and patient support/assistance programs).

He has over 20 years’ experience in the Pharma industry across multiple therapeutic areas and roles. Prior to joining the pharmaceutical industry, he practiced as a clinical pharmacist, and is trained in law, business, bioethics, and general management. He previously served as an industry representative over a 5-year period on the WHO/Roll-Back Malaria (RBM) case management working group and has managed various partnerships (Public-Private & Private-Private).

Paul is a member of the Royal Pharmaceutical Society of Great Britain (MRPharmS). He has a Doctorate in Clinical Pharmacy from the University of Florida, a first-class honors master’s degree in Pharmacy from the Sunderland School of Pharmacy in the UK, a qualifying Law degree from the College of Law in London (now University of Law), certificates in Global Health Delivery and Public Leadership from Harvard University, a Fellowship in Bioethics from the Harvard Medical School, and an executive MBA from the International Institute for Management Development (IMD) in Lausanne, Switzerland.

He is a regular speaker/panelist at conferences on Global Health, Patient Access, Medical Governance, and also publishes on these topics.